© 2020 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2020 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
November 11, 2020
The psychiatric prescribing clinician may be called upon to treat pain comorbid with bipolar disorder.
October 30, 2020
Although clinicians and patients may wish otherwise, the comorbidity of ADHD and bipolar disorder needs to be considered.
October 29, 2020
David Osser, MD, comments on the low priority of valproate for treating patients with bipolar disorder.
Is valproic acid dismissed out of hand? Three doctors discuss its potential as a treatment.
October 26, 2020
Oxcarbazepine might be considered for patients who you want to treat with carbamazepine for mania (as monotherapy or adjunct) but for whom it would be unsafe or who have been unable to tolerate it.
October 14, 2020
The risk of “false positive” screening in primary care settings is reduced by a thorough clinical evaluation.
Bipolar disorder screening scales have modest sensitivity; thus, a negative result does not preclude a clinical evaluation.
October 12, 2020
Alkermes plc’s new drug, ALKS 3831, pending FDA approval, could be helpful in the treatment of patients with schizophrenia or bipolar I disorder.
September 28, 2020
There are many reasons symptoms worsen in younger patients who are prescribed antidepressants. Five possible scenarios are discussed in this podcast.
September 14, 2020
Chris Aiken, MD, and Kellie Newsome, PMH-NP, discuss best practices for dosing quetiapine for the treatment of bipolar disorder.